---
title: "GH Analyst Ratings and Price Target - Guardant Health Stock Forecast | Tradytics"
description: "Guardant Health (GH) analyst ratings, the average price target and its range, and every firm's latest call."
url: "https://tradytics.com/research/GH/analysts"
image: "https://tradytics.com/api/v2/og/research.png?id=GH&v=stock-11994867"
---

# GH analyst estimates

Guardant Health (GH) analyst ratings, the average price target and its range, and every firm's latest call.

- 20 firms rate GH: 20 buy, 0 hold, 0 sell.
- The average price target is $203.40 from None analysts, from $180.00 to $225.00.

## GH analyst ratings and price targets

| Date | Firm | Call | Target |
| --- | --- | --- | --- |
| Oct 27, 2026 | BTIG | Guardant Health (GH) PT Raised to $210 at BTIG, remains Top Pick | $210.00 |
| Oct 12, 2026 | Morgan Stanley | Guardant Health price target raised to $200 from $185 at Morgan Stanley | $200.00 |
| Oct 7, 2026 | Barclays | Guardant Health price target raised to $220 from $200 at Barclays | $220.00 |
| Oct 1, 2026 | Guggenheim | Guardant Health price target raised to $200 from $190 at Guggenheim | $200.00 |
| Sep 10, 2026 | Bernstein | Bernstein SocGen Group Reiterates Outperform Rating on Guardant Health (GH) | $210.00 |
| Sep 9, 2026 | UBS | Guardant Health assumed with a Buy at UBS | $225.00 |
| Sep 8, 2026 | Redburn Partners | Guardant Health initiated with a Buy at Rothschild & Co Redburn | $203.00 |
| Aug 4, 2026 | Piper Sandler | Guardant Health price target raised to $193 from $135 at Piper Sandler | $193.00 |
| Aug 4, 2026 | Stephens | Guardant Health price target raised to $195 from $170 at Stephens | $195.00 |
| Aug 4, 2026 | Morgan Stanley | Guardant Health price target raised to $185 from $175 at Morgan Stanley | $185.00 |
| Jul 31, 2026 | Mizuho Securities | Guardant Health (GH) PT Raised to $200 at Mizuho | $200.00 |
| Jul 31, 2026 | Goldman Sachs | Guardant Health price target raised to $210 from $185 at Goldman Sachs | $210.00 |
| Jul 31, 2026 | Stifel Nicolaus | Guardant Health (GH) PT Raised to $180 at Stifel | $180.00 |
| Jul 31, 2026 | RBC Capital | Guardant Health (GH) PT Raised to $210 at TD Cowen | $210.00 |
| Jul 31, 2026 | RBC Capital | Guardant Health price target raised to $200 from $185 at RBC Capital | $200.00 |

- [GH stock analysis](https://tradytics.com/research/GH)
- [GH options overview](https://tradytics.com/research/GH/options)
- [GH earnings](https://tradytics.com/research/GH/earnings)
- [GH financials](https://tradytics.com/research/GH/financials)
- [GH peer analysis](https://tradytics.com/research/GH/peers)
- [GH insider trading](https://tradytics.com/research/GH/insiders)
- [GH congressional trades](https://tradytics.com/research/GH/politicians)
- [GH institutional holdings](https://tradytics.com/research/GH/funds)
- [GH live chart](https://tradytics.com/charts?s=GH)
- [Read the data without JavaScript](https://tradytics.com/research/GH/analysts?snapshot=1)
